150 related articles for article (PubMed ID: 30585697)
1. TSC2 genetic variant and prognosis in non-small cell lung cancer after curative surgery.
Lee YH; Do SK; Lee SY; Kang HG; Choi JE; Hong MJ; Lee JH; Lee EB; Jeong JY; Shin KM; Lee WK; Seok Y; Cho S; Yoo SS; Lee J; Cha SI; Kim CH; Jheon S; Park JY
Thorac Cancer; 2019 Feb; 10(2):335-340. PubMed ID: 30585697
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms in Epithelial-Mesenchymal Transition-Related Genes and the Prognosis of Surgically Treated Non-small Cell Lung Cancer.
Seok Y; Kang HG; Lee SY; Jeong JY; Choi JE; Jung DK; Jin CC; Hong MJ; Do SK; Lee WK; Park JY; Shin KM; Yoo SS; Lee J; Cho S; Cha SI; Kim CH; Jheon S; Lee EB; Park JY
Ann Surg Oncol; 2017 Oct; 24(11):3386-3395. PubMed ID: 28766235
[TBL] [Abstract][Full Text] [Related]
3. Genetic Variant of Notch Regulator DTX1 Predicts Survival After Lung Cancer Surgery.
Lee JH; Shin KM; Lee SY; Hong MJ; Choi JE; Kang HG; Do SK; Lee WK; Lee EB; Seok Y; Jeong JY; Yoo SS; Lee J; Cha SI; Kim CH; Cho S; Jheon S; Kim YC; Oh IJ; Na KJ; Kim MS; Lee JM; Yang HC; Jung CY; Park CK; Lee MK; Kim DK; Park JY
Ann Surg Oncol; 2019 Oct; 26(11):3756-3764. PubMed ID: 31313037
[TBL] [Abstract][Full Text] [Related]
4. Glucose Transporter 1 Gene Variants Predict the Prognosis of Patients with Early-Stage Non-small Cell Lung Cancer.
Do SK; Jeong JY; Lee SY; Choi JE; Hong MJ; Kang HG; Lee WK; Seok Y; Lee EB; Shin KM; Yoo SS; Lee J; Cha SI; Kim CH; Neugent ML; Goodwin J; Kim JW; Park JY
Ann Surg Oncol; 2018 Oct; 25(11):3396-3403. PubMed ID: 30062472
[TBL] [Abstract][Full Text] [Related]
5. Association between genetic variants in pre-microRNAs and survival of early-stage NSCLC.
Hong MJ; Choi YY; Jang JA; Jung HJ; Lee SY; Lee WK; Yoo SS; Lee J; Cha SI; Kim CH; Lee E; Jeon HS; Son JW; Park JY
J Thorac Oncol; 2013 Jun; 8(6):703-10. PubMed ID: 23470291
[TBL] [Abstract][Full Text] [Related]
6. Genetic Polymorphisms in Activating Transcription Factor 3 Binding Site and the Prognosis of Early-Stage Non-Small Cell Lung Cancer.
Kang HG; Park JE; Lee SY; Choi JE; Do SK; Hong MJ; Lee JH; Jeong JY; Do YW; Lee EB; Shin KM; Lee WK; Choi SH; Lee YH; Seo HW; Yoo SS; Lee J; Cha SI; Kim CH; Cho S; Jheon S; Park JY
Oncology; 2021; 99(5):336-344. PubMed ID: 33626541
[TBL] [Abstract][Full Text] [Related]
7. KRAS genetic variant as a prognostic factor for recurrence in resectable non-small cell lung cancer.
Sullivan I; Salazar J; Arqueros C; Andrés M; Sebio A; Majem M; Szafranska J; Martínez E; Páez D; López-Pousa A; Baiget M; Barnadas A
Clin Transl Oncol; 2017 Jul; 19(7):884-890. PubMed ID: 28150169
[TBL] [Abstract][Full Text] [Related]
8. A functional polymorphism on chromosome 15q25 associated with survival of early stage non-small-cell lung cancer.
Jin G; Bae EY; Yang E; Lee EB; Lee WK; Choi JE; Jeon HS; Yoo SS; Lee SY; Lee J; Cha SI; Kim CH; Cho S; Jheon S; Park JY
J Thorac Oncol; 2012 May; 7(5):808-14. PubMed ID: 22722785
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of tumor-infiltrating lymphocytes for patients with completely resected stage IIIA(N2) non-small cell lung cancer.
Feng W; Li Y; Shen L; Cai XW; Zhu ZF; Chang JH; Xiang JQ; Zhang YW; Chen HQ; Fu XL
Oncotarget; 2016 Feb; 7(6):7227-40. PubMed ID: 26811495
[TBL] [Abstract][Full Text] [Related]
10. Glucose transporter 3 gene variant is associated with survival outcome of patients with non-small cell lung cancer after surgical resection.
Do SK; Choi SH; Lee SY; Choi JE; Hong MJ; Kang HG; Lee WK; Lee EB; Shin KM; Jeong JY; Lee YH; Seo H; Yoo SS; Lee J; Cha SI; Kim CH; Seok Y; Cho S; Jheon S; Park JY
Gene; 2019 Jun; 703():58-64. PubMed ID: 30954677
[TBL] [Abstract][Full Text] [Related]
11. The prognostic value of ratio-based lymph node staging in resected non-small-cell lung cancer.
Qiu C; Dong W; Su B; Liu Q; Du J
J Thorac Oncol; 2013 Apr; 8(4):429-35. PubMed ID: 23486264
[TBL] [Abstract][Full Text] [Related]
12. AKT1 polymorphisms and survival of early stage non-small cell lung cancer.
Kim MJ; Kang HG; Lee SY; Jeon HS; Lee WK; Park JY; Lee EB; Lee JH; Cha SI; Kim DS; Kim CH; Kam S; Jung TH; Park JY
J Surg Oncol; 2012 Feb; 105(2):167-74. PubMed ID: 21842521
[TBL] [Abstract][Full Text] [Related]
13. Surgery for young patients with lung cancer.
Tian DL; Liu HX; Zhang L; Yin HN; Hu YX; Zhao HR; Chen DY; Han LB; Li Y; Li HW
Lung Cancer; 2003 Nov; 42(2):215-20. PubMed ID: 14568689
[TBL] [Abstract][Full Text] [Related]
14. Long-term oncologic results for robotic major lung resection in non-small cell lung cancer (NSCLC) patients.
Zirafa CC; Cavaliere I; Ricciardi S; Romano G; Davini F; Aprile V; Melfi F
Surg Oncol; 2019 Mar; 28():223-227. PubMed ID: 30851905
[TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of number of resected and involved lymph nodes at complete resection on survival in non-small cell lung cancer.
Saji H; Tsuboi M; Yoshida K; Kato Y; Nomura M; Matsubayashi J; Nagao T; Kakihana M; Usuda J; Kajiwara N; Ohira T; Ikeda N
J Thorac Oncol; 2011 Nov; 6(11):1865-71. PubMed ID: 21964529
[TBL] [Abstract][Full Text] [Related]
16. Survival differences by gender for resected non-small cell lung cancer: a retrospective analysis of 12,509 cases in a Japanese Lung Cancer Registry study.
Sakurai H; Asamura H; Goya T; Eguchi K; Nakanishi Y; Sawabata N; Okumura M; Miyaoka E; Fujii Y;
J Thorac Oncol; 2010 Oct; 5(10):1594-601. PubMed ID: 20736855
[TBL] [Abstract][Full Text] [Related]
17. Extracapsular extension is a powerful prognostic factor in stage IIA-IIIA non-small cell lung cancer patients with completely resection.
Liu W; Shao Y; Guan B; Hao J; Cheng X; Ji K; Wang K
Int J Clin Exp Pathol; 2015; 8(9):11268-77. PubMed ID: 26617851
[TBL] [Abstract][Full Text] [Related]
18. Tumour islet Foxp3+ T-cell infiltration predicts poor outcome in nonsmall cell lung cancer.
O'Callaghan DS; Rexhepaj E; Gately K; Coate L; Delaney D; O'Donnell DM; Kay E; O'Connell F; Gallagher WM; O'Byrne KJ
Eur Respir J; 2015 Dec; 46(6):1762-72. PubMed ID: 26541534
[TBL] [Abstract][Full Text] [Related]
19. TNFRSF10B polymorphisms and haplotypes associated with increased risk of death in non-small cell lung cancer.
Schabath MB; Giuliano AR; Thompson ZJ; Amankwah EK; Gray JE; Fenstermacher DA; Jonathan KA; Beg AA; Haura EB
Carcinogenesis; 2013 Nov; 34(11):2525-30. PubMed ID: 23839018
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneity of stage IIIA non-small cell lung cancers (NSCLC) and evaluation of late results of surgical treatment.
Gawrychowski J; Gabriel A; Lackowska B
Eur J Surg Oncol; 2003 Mar; 29(2):178-84. PubMed ID: 12633562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
